全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Liver Histological Patterns among HIV-Infected Individuals and Associated Factors of Fibrosis in Northwestern Tanzania: Is There a Role for Non-Invasive Tests?

DOI: 10.4236/oalib.1113760, PP. 1-10

Subject Areas: HIV, Gastroenterology & Hepatology

Keywords: HIV, Fibrosis, Non-Invasive Tests, Ultrasound-Guided Biopsy

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: There is a paucity of data on HIV related liver pathologies and fibrosis in Tanzania, a lower middle income country, where there is a high burden of HIV and empirical treatment is the norm due to lack of investigative and management guidelines. This study aimed to determine the liver histological patterns among HIV-infected individuals and associated factors of fibrosis, as well as the role of non-invasive tests in the detection of fibrosis. Patients and Methods: This was an analytical cross-sectional hospital-based study carried out in Mwanza, Tanzania. HIV-infected individuals with suspected but indeterminate liver disease underwent ultrasound guided liver biopsy to determine histological patterns. Non-invasive tests, APRI and FIB-4, were com-pared with ultrasound-guided liver biopsy in the detection of fibrosis. Logistic regression analyses were performed to assess the association between outcome and exposure variables with a p-value < 0.05 considered statistically significant. Receiver operating characteristic curve analyses were used to compare APRI and FIB-4 performance against ultrasound-guided liver biopsy for the detection of liver fibrosis. Results: A total of 86 participants underwent an ultrasound-guided biopsy and specimen for histopathology. Around 98% of the study participants had histological abnormalities. There was underlying fibrosis in 54.7% of the participants with the second most common histological pattern being chronic hepatitis (48.9%). Other patterns included malignancy (24.4%) with the majority having hepatocellular carcinoma (HCC). Steatosis or steatohepatitis was present in 17.4%. Granulomatous inflammation was seen in 13.9% with the majority being tuberculous in origin. APRI and FIB-4 reported a lower proportion of fibrosis compared to histology. Advanced age (OR = 4.78, 95% CI =1.64 - 13.91), presence of jaundice (OR = 3.59, 95% CI = 1.27 - 10.16) or hepatomegaly (OR = 3.56, 95% CI = 1.25 - 10.16) were independent predictors of fibrosis. On receiver operating characteristic analyses, FIB-4 performed marginally better than APRI in detecting fibrosis in comparison to histology (AUC = 0.56, 95% CI = 0.46 - 0.67 vs. AUC = 0.51, 95% CI = 0.39 - 0.61). Conclusions and Recommendation: Fibrosis is the most prevalent histological pattern among HIV-infected individuals. FIB-4 performed better than APRI as a non-invasive test for detecting fibrosis in comparison to histology. We recommend non-invasive tests for screening underlying fibrosis in HIV-infected individuals.

Cite this paper

Maseke, R. , Manyiri, P. , Majinge, D. , Kidola, J. , Rambau, P. , Kalluvya, S. and Ngoya, P. S. (2025). Liver Histological Patterns among HIV-Infected Individuals and Associated Factors of Fibrosis in Northwestern Tanzania: Is There a Role for Non-Invasive Tests?. Open Access Library Journal, 12, e3760. doi: http://dx.doi.org/10.4236/oalib.1113760.

References

[1]  The Tanzania HIV Impact Survey 2022-2023 (THIS 2022-2023). https://www.nbs.go.tz/statistics/topic/the-tanzania-hiv-impact-survey
[2]  Sherman, K.E., Rockstroh, J. and Thomas, D. (2015) Hu-man Immunodeficiency Virus and Liver Disease: An Update. Hepatology, 62, 1871-1882. https://doi.org/10.1002/hep.28150
[3]  Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., et al. (2021) EASL Clinical Practice Guidelines on Non-Invasive Tests for Evaluation of Liver Disease Severity and Prognosis—2021 Up-date. Journal of Hepatology, 75, 659-689. https://doi.org/10.1016/j.jhep.2021.05.025
[4]  Lin, K.W., Kumar, R., Shen, F., Chan, H.L., Wong, G.L., Kumar, R., et al. (2023) The Utility of Non-Invasive Tests to Assess Advanced Fibrosis in Asian Subjects with Chronic Hepatitis B and Concomitant Hepatic Steatosis. Liver International, 43, 1008-1014. https://doi.org/10.1111/liv.15541
[5]  Rockey, D.C., Caldwell, S.H., Goodman, Z.D., Nelson, R.C. and Smith, A.D. (2009) Liver Biopsy. Hepatology, 49, 1017-1044. https://doi.org/10.1002/hep.22742
[6]  Hoffmann, C.J., Hoffmann, J.D., Kensler, C., van der Watt, M., Omar, T., Chaisson, R.E., et al. (2015) Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa. PLOS ONE, 10, e0117813. https://doi.org/10.1371/journal.pone.0117813
[7]  Wai, C., Greenson, J.K., Fontana, R.J., Kalbfleisch, J.D., Marrero, J.A., Conjeevaram, H.S., et al. (2003) A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C. Hepatology, 38, 518-526. https://doi.org/10.1053/jhep.2003.50346
[8]  Vallet-Pichard, A., Mallet, V., Nalpas, B., Verkarre, V., Nalpas, A., Dhalluin-Venier, V., et al. (2007) FIB-4: An Inexpensive and Accurate Marker of Fibrosis in HCV Infection. Comparison with Liver Biopsy and Fibrotest. Hepatology, 46, 32-36. https://doi.org/10.1002/hep.21669
[9]  Platt, L., French, C.E., McGowan, C.R., Sabin, K., Gower, E., Trickey, A., et al. (2019) Prev-alence and Burden of HBV Co-Infection among People Living with HIV: A Global Systematic Review and Meta-Analysis. Journal of Viral Hepatitis, 27, 294-315. https://doi.org/10.1111/jvh.13217
[10]  Hawkins, C., Christian, B., Fabian, E., Macha, I., Gawile, C., Mpangala, S., et al. (2017) Brief Report: HIV/HBV Coinfection Is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76, 298-302. https://doi.org/10.1097/qai.0000000000001491
[11]  Xu, M., Warner, C., Duan, X., Cheng, Z., Jeyarajan, A.J., Li, W., et al. (2024) HIV Coinfection Exacerbates HBV-Induced Liver Fibrogenesis through a HIF-1α- and TGF-β1-Dependent Pathway. Journal of Hepatology, 80, 868-881. https://doi.org/10.1016/j.jhep.2024.01.026
[12]  Surial, B., Wyser, D., Béguelin, C., Ramírez‐Mena, A., Rauch, A. and Wandeler, G. (2020) Prevalence of Liver Cirrhosis in Individuals with Hepatitis B Virus Infection in Sub-Saharan Afri-ca: Systematic Review and Meta-Analysis. Liver International, 41, 710-719. https://doi.org/10.1111/liv.14744
[13]  Maponga, T.G., Glashoff, R.H., Vermeulen, H., Robertson, B., Burmeister, S., Bernon, M., et al. (2020) Hepatitis B Virus-Associated Hepatocellular Carcinoma in South Africa in the Era of HIV. BMC Gastroenterology, 20, Article No. 226. https://doi.org/10.1186/s12876-020-01372-2
[14]  Otedo, A., Simbiri, K.O., Were, V., Ongati, O. and Estambale, B.A. (2018) Risk Factors for Liver Cancer in HIV Endemic Areas of Western Kenya. Infectious Agents and Cancer, 13, Article No. 41. https://doi.org/10.1186/s13027-018-0214-5
[15]  Maurice, J.B., Patel, A., Scott, A.J., Patel, K., Thursz, M. and Lemoine, M. (2017) Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in HIV-Monoinfection. AIDS, 31, 1621-1632. https://doi.org/10.1097/qad.0000000000001504
[16]  Malindisa, E., Balandya, E., Njelekela, M., Kidenya, B.R., Francis, F., Mmbaga, B.T., et al. (2023) Metabolic Syndrome among People Living with HIV on Antiretroviral Therapy in Mwanza, Tanzania. BMC Endo-crine Disorders, 23, Article No. 88. https://doi.org/10.1186/s12902-023-01340-3
[17]  Sonderup, M.W., Wainwright, H., Hall, P., Hairwadzi, H. and Spearman, C.W.N. (2015) A Clinicopathological Cohort Study of Liver Pathology in 301 Patients with Human Im-munodeficiency Virus/acquired Immune Deficiency Syndrome. Hepatology, 61, 1721-1729. https://doi.org/10.1002/hep.27710
[18]  Pereira, G.H., Yamagutti, D.C.C. and Mendonça, J.S.D. (2010) Evaluation of the Histopatho-logical Hepatic Lesions and Opportunistic Agents in Brazilian HIV Patients. Revista da Sociedade Brasileira de Medicina Tropical, 43, 1-3. https://doi.org/10.1590/s0037-86822010000100001
[19]  Gür-Altunay, D. and Yürük-Atasoy, P. (2023) How Successful Are APRI and FIB-4 Scores in Predicting Liver Fibrosis in Chronic Hepatitis B Patients? Infectious Diseases and Clinical Microbiology, 5, 332-340. https://doi.org/10.36519/idcm.2023.276
[20]  Debes, J.D., Bohjanen, P.R. and Boonstra, A. (2016) Mechanisms of Acceler-ated Liver Fibrosis Progression during HIV Infection. Journal of Clinical and Translational Hepatology, 4, 328-335. https://doi.org/10.14218/JCTH.2016.00034

Full-Text


Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133